RESULTS for GlaxoSmithKline in 2016 were ahead of what the market was expecting, with sales up 6 per cent and core operating profits up 14 per cent.
Source: Daily Express :: Finance Feed http://ift.tt/2lFO46G
Share Hunter: US competition overshadows GSK progress
RESULTS for GlaxoSmithKline in 2016 were ahead of what the market was expecting, with sales up 6 per cent and core operating profits up 14 per cent.
Source: Daily Express :: Finance Feed http://ift.tt/2lFO46G
EmoticonEmoticon